Virology Specimen Collection Market | Rising Prevalence of Viral Diseases and Increasing Prevalence of Human Papillomavirus (HPV)

According to Precision Business Insights (PBI), the latest report the global Virology Specimen Collection market is expected to be worth USD 5,287.3 million in 2021 and projected to grow at a 4.8% CAGR over 2022 to 2028. The rising number of Babesia cases and Zika virus incidence are seen as important growth drivers for the global virology specimen collection. Furthermore, the growing need for innovation in virology specimen collecting tools, consumables, and technologies would benefit this market from 2022 to 2028. Similarly, the increased frequency of mosquito-borne transmission diseases will drive the global virology specimen collecting market in the upcoming years.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/virology-specimen-collection-market/

The Virology Transport Media Segment is Dominating the Virology Specimen Collection Market:
The virology transport media segment is expected to account for a larger revenue share. The market is anticipated to grow at a double-digit growth rate over the forecast years due to increased demand for swabs and viral transport medium due to the present COVID-19 epidemic. The significant increase in COVID-19 diagnostic tests, the rise in the number of COVID-19 cases, and the expansion of the diagnostics sector are expected to drive the global market over the projected period.

North America Leads Virology Specimen Collection Market:
North America is anticipated to hold a significant Market share in the global Virology Specimen Collection market and is projected to grow at a prominent growth rate over the forecast years owing to the increased use of NAT (due to the high prevalence of TTIs) and technical advancements such as portable diagnostics. Moreover Asia-Pacific, on the other hand, is expected to develop at the fastest rate between 2022 and 2028. Growing disposable income, rising injury rates, and better healthcare infrastructure would generate profitable growth opportunities for the Asia-Pacific Virology Specimen Collection market.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global Virology Specimen Collection market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In February 2020, BD partnered with Babson Diagnostic to enable small-volume blood collection for diagnostic testing. In November 2020, Mybiopassport launched "COVID-19 & Immunity Profile" test, that helps to determine if the individual has been previously infected by COVID-19 through the development of specific antibodies.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=60699

The virology specimen collection market is segmented based on product type, sample, and geography:
Based on the Product Type, the market is segmented into the following:
• Blood Collection Kits
• Specimen Collection Tubes
• Viral Transport Media
• Swabs

Based on the Sample, the market is segmented into the following:
• Blood Samples
• Nasopharyngeal Samples
• Throat Samples
• Nasal Sampls
• Cervical Samples
• Oral Samples
• Other Samples

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=60699

Key player's profiles in the Virology Specimen Collection Market report are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific Inc. (US), Trinity Biotech (Ireland), Titan Biotech Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.P.A (Italy), Puritan Medical Products Co, and Hardy Diagnostics (US).

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.